Pan Cancer T are EIT Health Catapult Finalists

Pan Cancer T are EIT Health Catapult Finalists

On 5th June, our CEO, Rachel Abbott, was pleased to represent Pan Cancer T in the EIT Health Catapult finals at the health.tech global summit in Munich. This marks the culmination of the EIT Health Catapult program, a unique competition and training programme that...
Poster Presentation

Poster Presentation

Pan Cancer T is presenting preclinical data at CIMT and SITC 2023. Dora Hammerl, PCT’s co-founder and VP R&D will present preclinical data on their lead program PCT1 focusing on target and TCR identification. Link to poster: PCT1 poster...